36 Healthcare Stocks Moving In Wednesday's After-Market Session

Gainers

• Innovate, Inc. INNT stock surged 29.2% to $0.85 during Wednesday's after-market session.

• Genprex, Inc. GNPX shares moved upwards by 14.8% to $2.17.

• Alector, Inc. ALEC shares surged 11.2% to $25.50. The most recent rating by BTIG, on November 21, is at Buy, with a price target of $28.00.

• Ritter Pharmaceuticals, Inc. RTTR stock moved upwards by 6.4% to $0.21.

• Solid Biosciences, Inc. SLDB stock rose 5.9% to $3.95. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.

• Sierra Oncology, Inc. SRRA stock rose 5.8% to $0.37. The most recent rating by Oppenheimer, on December 06, is at Outperform, with a price target of $1.20.

• Marinus Pharmaceuticals, Inc. MRNS stock rose 5.8% to $2.38. The most recent rating by H.C. Wainwright, on January 10, is at Buy, with a price target of $6.00.

• Achieve Life Sciences, Inc. ACHV stock increased by 5.5% to $0.63.

• Unum Therapeutics, Inc. UMRX stock rose 5.0% to $1.25. The most recent rating by Morgan Stanley, on November 27, is at Overweight, with a price target of $3.00.

• Affimed, Inc. AFMD stock increased by 4.5% to $3.03.

• Osmotica Pharmaceuticals, Inc. OSMT stock increased by 4.3% to $6.99.

• Organovo Holdings, Inc. ONVO stock increased by 4.3% to $0.38.

• Precipio, Inc. PRPO stock surged 4.3% to $2.20. The most recent rating by Maxim Group, on November 22, is at Buy, with a price target of $4.00.

• Neurotrope, Inc. NTRP stock increased by 4.2% to $1.48.

• InMode, Inc. INMD stock surged 4.1% to $48.05. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.

• Teligent, Inc. TLGT shares increased by 3.6% to $0.43.

• MannKind, Inc. MNKD stock surged 3.5% to $1.75. According to the most recent rating by Oppenheimer, on December 24, the current rating is at Outperform.

• Akerna, Inc. KERN shares increased by 3.5% to $8.82.

• Nektar Therapeutics, Inc. NKTR stock surged 3.3% to $22.87. The most recent rating by JP Morgan, on November 13, is at Neutral, with a price target of $28.00.

• Oncolytics Biotech, Inc. ONCY stock increased by 3.3% to $3.46.

• Lexicon Pharmaceuticals, Inc. LXRX stock increased by 3.2% to $3.89. According to the most recent rating by Gabelli & Co., on December 11, the current rating is at Hold.

• Baudax Bio, Inc. BXRX stock moved upwards by 3.2% to $8.80.

• HEXO, Inc. HEXO stock rose 3.1% to $1.48.

• Jaguar Health, Inc. JAGX shares increased by 3.0% to $0.85. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $3.00.

Losers

• Tetraphase Pharmaceutical, Inc. TTPH stock fell 23.2% to $2.95 during Wednesday's after-market session. The most recent rating by Gabelli & Co., on October 31, is at Buy, with a price target of $5.00.

• Karuna Therapeutics, Inc. KRTX shares plummeted 12.1% to $101.35. The most recent rating by Wells Fargo, on January 22, is at Overweight, with a price target of $137.00.

• Dare Bioscience, Inc. DARE shares declined 11.8% to $1.50.

• Trillium Therapeutics, Inc. TRIL shares fell 10.6% to $2.92.

• Option Care Health, Inc. BIOS shares declined 8.0% to $4.01.

• Concert Pharmaceuticals, Inc. CNCE stock fell 5.3% to $12.40.

• Midatech Pharma, Inc. MTP stock decreased by 5.1% to $0.84.

• Axonics Modulation Tech, Inc. AXNX shares plummeted 4.8% to $30.02. The most recent rating by SunTrust Robinson Humphrey, on January 08, is at Buy, with a price target of $38.00.

• Biocept, Inc. BIOC stock decreased by 3.5% to $0.33.

• vTv Therapeutics, Inc. VTVT shares declined 3.5% to $2.50.

• Xenon Pharmaceuticals, Inc. XENE stock plummeted 3.5% to $16.25. According to the most recent rating by William Blair, on January 08, the current rating is at Outperform.

• Titan Pharmaceuticals, Inc. TTNP shares decreased by 3.3% to $0.32.